Interleukin-10 polymorphisms in Spanish multiple sclerosis patients

Journal of Neuroimmunology

Volumn 131, Issue 1-2, 2002, Pages 168-172

  Martinez Doncel, Alfonso ^a   Rubio, Ana ^a   Arroyo, Rafael ^a   De las Heras, Virginia ^a   Martín, Carlos ^a   Fernandez Arquero, Miguel ^a   De la Concha, Emilio G ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Genetic polymorphism; Interleukin 10; Multiple sclerosis

Indexed keywords

INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MALE; MICROSATELLITE REPEATS; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10;

EID: 0036792037     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00248-5     Document Type: Article

References (28)

1. Bell J.I., Lathrop G.M. Multiple loci for multiple sclerosis. Nat. Genet. 13:1996;377-378.
2. Cavet J., Middleton P.G., Segall M., Noreen H., Davies S.M., Dickinson A.M. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associated with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 94:1999;3941-3946.
3. Crawley E., Kay R., Sillibourne J., Patel P., Hutchinson I., Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription, and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 42:1999;1101-1108.
4. Cua D.J., Hutchins B., LaFace D.M., Stohlman S.A., Coffman R.L. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166:2001;602-608.
5. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R.B., Hader W., Paty D.W., Hashimoto S., Oger J., Duquette P., Warren S., Gray T., O'Connor P., Nath A., Auty A., Metz L., Francis G., Paulseth J.E., Murray T.J., Pryse-Phillips W., Risch N.et al. A full genome search in multiple sclerosis. Nat. Genet. 13:1996;472-476.
6. Eskdale J., Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics. 42:1995;444-445.
7. Eskdale J., Kube D., Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics. 45:1996;82-83.
8. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics. 46:1997;120-128.
9. Eskdale J., Wordsworth P., Bowman S., Field M., Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens. 49:1997;635-639.
10. Eskdale J., Gallagher G., Verweij C.L., Keijsers V., Westendorp R.G., Huizinga T.W. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9465-9470.
11. Eskdale J., Keijsers V., Huizinga T., Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun. 1:1999;151-155.
12. Gayo A., Mozo L., Suarez A., Tunon A., Lahoz C., Gutierrez C. Long-term effect of IFNbeta1b treatment on the spontaneous and induced expression of IL-10 and TGFbeta1 in MS patients. J. Neurol. Sci. 179:2000;43-49.
13. Gibson A.W., Edberg J.C., Wu J., Westendorp R.G., Huizinga T.W., Kimberly R.P. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 166:2001;3915-3922.
14. Haines J.L., Ter-Minassian M., Bazyk A., Gusella J.F., Kim D.J., Terwedow H., Pericak-Vance M.A., Rimmler J.B., Haynes C.S., Roses A.D., Lee A., Shaner B., Menold M., Seboun E., Fitoussi R.P., Gartioux C., Reyes C., Ribierre F., Gyapay G., Weissenbach J., Hauser S.L., Goodkin D.E., Lincoln R., Usuku K., Oksenberg J.R.et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat. Genet. 13:1996;469-471.
15. He B., Xu C., Yang B., Landtblom A.M., Fredrikson S., Hillert J. Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. J. Neuroimmunol. 86:1998;13-19.
16. Karp C.L., Biron C.A., Irani D.N. Interferon beta in multiple sclerosis: is IL-12 suppression the key? Immunol. Today. 21:2000;24-28.
17. Karp C.L., van Boxel-Dezaire A.H., Byrnes A.A., Nagelkerken L. Interferon-beta in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10? Curr. Opin. Neurol. 14:2001;361-368.
18. Kuokkanen S., Sundvall M., Terwilliger J.D., Tienari P.J., Wikstrom J., Holmdahl R., Pettersson U., Peltonen L. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat. Genet. 13:1996;477-480.
19. Martinez A., Fernandez-Arquero M., Balsa A., Rubio A., Alves H., Pascual-Salcedo D., Martin-Mola E., de la Concha E.G. Primary association of a MICA allele with protection against rheumatoid arthritis. Arthritis Rheum. 44:2001;1261-1265.
20. Maurer M., Kruse N., Giess R., Toyka K.V., Rieckmann P. Genetic variation at position-1082 of the interleukin 10 (IL-10) promotor and the outcome of multiple sclerosis. J. Neuroimmunol. 104:2000;98-100.
21. McDonnell G.V., Kirk C.W., Hawkins S.A., Graham C.A. An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. J. Neurol. Sci. 176:2000;4-12.
22. Mullighan C.G., Marshall S.E., Bunce M., Welsh K.I. Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency. Genes Immun. 1:1999;137-148.
23. Noseworthy J.H. Progress in determining the causes and treatment of multiple sclerosis. Nature. 399:1999;A40-A47.
24. Pickard C., Mann C., Sinnott P., Boggild M., Hawkins C., Strange R.C., Hutchinson I.V., Ollier W.E., Donn R.P. Interleukin-10 (IL-10) promoter polymorphisms and multiple sclerosis. J. Neuroimmunol. 101:1999;207-210.
25. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13:1996;464-468.
26. Turner D., Grant S.C., Yonan N., Sheldon S., Dyer P.A., Sinnott P.J., Hutchinson I.V. Cytokine gene polymorphism and heart transplant rejection. Transplantation. 64:1997;776-779.
27. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24:1997;1-8.
28. Zang Y.C., Yang D., Hong J., Tejada-Simon M.V., Rivera V.M., Zhang J.Z. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS. Neurology. 55:2000;397-404.